Dose optimization and active-dose strategy

Rank candidate doses by benefit-risk, not dose alone.

Dose Optimus Studio compares candidate doses using exposure-response, safety ceilings, information strength, uncertainty gaps, and next-study needs so teams can carry a defensible active-dose set forward.

Open Credibility Studio
Recommended anchor dose

BPK-201 dose optimization

Candidate active dose
160 mg
Backend ready
Exposure-response and safety

Candidate dose profiles

Dose ranking

Benefit-risk utility

Active dose set

Retain for review

Next study

Recommended actions